Press Releases

Crucial Data Solutions Forms Partnership with Durham Tech to Support Clinical Research Education

Durham Tech’s clinical trials program utilizes TrialKit, a data collection and study management platform from Crucial Data Solutions

Alfa Chemistry Offers PEG linkers for the Science Community in Bioconjugation and Pegylation

Alfa Chemistry announced that a total of close to 800 PEG linker products are now available for its customers worldwide.

AI & Medicine — An Expert in AI-aided Drug Discovery and Medical Applications

AI & Medicine successfully develops an AI-powered drug discovery platform for medical institutions and pharmaceutical enterprises across the globe.

eClinical Solutions Unveils Roadmap for Clinical Trials During COVID-19 Pandemic

With 60% of trials on hold, Boston pharma tech innovator offers a route for advancing drug development using AI and novel data strategies

Clinical Ink Study Assurance Program Waives Millions of Dollars in Change Order Fees for Ongoing Clinical Trials

Clinical Ink has announced a wide-ranging Study Assurance Program to minimize financial impact of the disruption from COVID-19 on new and existing clinical trials.

Creative Biolabs’ Free Webinar: Dr. Eytan Herzig Discusses Novel HIV Treatment

As one of the most threatening diseases, HIV has been studied for dozens of years. Recently, convertibleCAR-T Cells have been a hot issue in HIV treatment and Creative Biolabs has invited Dr. Eytan Herzig to share some information about it.

MR Solutions now offers the widest range of preclinical nuclear medicine imaging systems of any manufacturer

A world leader in helium free MRI systems for preclinical research laboratories MR Solutions has now developed the largest and most advanced range of preclinical nuclear medicine combination systems of any manufacturer - MR Solutions’ nuclear medicine range has 34 preclinical scanning configurations.

Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm

A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today by Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, and CytoAgents, Inc., a privately held biotechnology company focused on the development of pharmaceutical products for the treatment of viral infectious diseases.

Creative Diagnostics Launches SARS-CoV-2 Antigens and Antibodies for Research Use

Creative Diagnostics launches SARS-CoV-2 antigens and antibodies for global researchers.

PHARMASEAL expands Engility® Trial Management Platform with the addition of eTMF Document Storage

PHARMASEAL, an innovative provider of enterprise trial management solutions expands the capability of the Engility® clinical trial management platform. Electronic trial master file (eTMF) document storage is now available alongside Clinical Trial Management (CTMS) in the same integrated platform with enhanced productivity and operational benefits.

Chris O’Brien Lifehouse Hospital Ensures High Availability in the AWS Cloud with SIOS DataKeeper

AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to Meet Potential COVID-19 Demand

AMRI is increasing production of hydroxychloroquine sulfate API at its Rensselaer, N.Y., manufacturing facility to meet the rise in demand resulting from potential effectiveness of the product in treating COVID-19 symptoms.

The New Technology CAR-T Is Expected to Overcome AIDS After Being Transformed

HIV continues to be a major global public health issue, having claimed more than 32 million lives so far. However, the increasing access to effective HIV prevention, diagnosis and treatment has made it less threatening. Recently, convertibleCAR-T cell has been a hot issue for its great power to kill HIV-infected cells.

GlobalMed Offers Free Consultations to Healthcare Organizations Under Pressure to Implement Telehealth to Handle COVID-19 Surge

Provider community needs virtual technology, clinical guidance and proven telehealth implementation strategies to combat coronavirus. GlobalMed is offering a free consultative session for care providers, practices, and health systems interested in deploying telehealth.

Rho Experts Share Regulatory Best Practices on Product Development for the New Coronavirus

Free webinar offers insight into pathways to engage with Food and Drug Administration for COVID-19 product development

Ubiquitome targets testing travellers for COVID-19

Noxopharm Achieves Abscopal Responses in Prostate Cancer

Noxopharm is the first to achieve a meaningful abscopal responses in prostate cancer. Noxopharm reports a 27% incidence of abscopal response in soft tissue lesions using a combination of Veyonda® and low-dose radiotherapy.

Halfpenny Technologies, an Accumen Company, Launches COVID-19 Test Capacity and Routing Network Across 870 U.S. Hospitals to Accelerate Diagnostic Testing

This network uses a secure, cloud-based hub-and-spoke approach to process COVID-19 test orders and direct them efficiently to the nearest laboratory with capacity.

Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, PET-MR imaging system

Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, 7T PET-MR imaging system for preclinical research into inflammation, oncology and nephritis.

KCR’s Bryan Katz named in PM360’s ELITE 100

KCR, the international clinical development solutions provider, announced today that its Chief Commercial Officer, Bryan Katz, was honored by healthcare marketing industry trade magazine PM360 as one of their 2020 ELITE 100 award winners.